Skip to main content
Fig. 5 | BMC Complementary Medicine and Therapies

Fig. 5

From: Protective effect of Palmijihwanghwan in a mouse model of cigarette smoke and lipopolysaccharide-induced chronic obstructive pulmonary disease

Fig. 5

Effects of PJH on CS/LPS-induced changes in mRNA expression of cytokines in lung tissue. Quantitative PCR was performed to measure the levels of TNF-α (A), IL-6 (B) and IL-1β (C). CON: control group; CS + LPS group: CS/LPS-exposed; RO group: administration of roflumilast 10 mg/kg prior to CS/LPS exposure; PJH100 group: administration of PJH 100 mg/kg prior to CS/LPS exposure; PJH 200 group: administration of PJH 200 mg/kg prior to CS/LPS exposure. Results are presented as means ± SD (#P < 0.05, ##P < 0.01 compared with the CON group; *P < 0.05, **P < 0.01 compared with the CS + LPS group)

Back to article page